ArticleAnnals of medicine and surgery (2012)2025

METTL9 as a protein biomarker predicts the prognosis and immunotherapy response of skin-cutaneous melanoma.

Song Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.